Annual Retained Earnings
$118.35 B
-$7.30 B-5.81%
31 December 2023
Summary:
Pfizer annual retained earnings is currently $118.35 billion, with the most recent change of -$7.30 billion (-5.81%) on 31 December 2023. During the last 3 years, it has risen by +$27.96 billion (+30.93%). PFE annual retained earnings is now -5.81% below its all-time high of $125.66 billion, reached on 31 December 2022.PFE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$121.06 B
+$4.46 B+3.83%
30 September 2024
Summary:
Pfizer quarterly retained earnings is currently $121.06 billion, with the most recent change of +$4.46 billion (+3.83%) on 30 September 2024. Over the past year, it has dropped by -$5.35 billion (-4.23%). PFE quarterly retained earnings is now -7.66% below its all-time high of $131.10 billion, reached on 31 March 2023.PFE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.8% | -4.2% |
| 3 y3 years | +30.9% | +18.4% |
| 5 y5 years | +32.2% | +20.9% |
PFE Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.8% | +30.9% | -7.7% | +18.4% |
| 5 y | 5 years | -5.8% | +32.2% | -7.7% | +33.9% |
| alltime | all time | -5.8% | +5286.3% | -7.7% | +6223.4% |
Pfizer Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $121.06 B(+3.8%) |
| June 2024 | - | $116.60 B(-3.9%) |
| Mar 2024 | - | $121.32 B(+2.5%) |
| Dec 2023 | $118.35 B(-5.8%) | $118.35 B(-6.4%) |
| Sept 2023 | - | $126.41 B(-1.9%) |
| June 2023 | - | $128.80 B(-1.8%) |
| Mar 2023 | - | $131.10 B(+4.3%) |
| Dec 2022 | $125.66 B(+21.5%) | $125.66 B(+2.2%) |
| Sept 2022 | - | $122.97 B(+5.5%) |
| June 2022 | - | $116.61 B(+4.9%) |
| Mar 2022 | - | $111.19 B(+7.5%) |
| Dec 2021 | $103.39 B(+14.4%) | $103.39 B(+1.1%) |
| Sept 2021 | - | $102.25 B(+6.1%) |
| June 2021 | - | $96.35 B(+1.2%) |
| Mar 2021 | - | $95.16 B(+5.3%) |
| Dec 2020 | $90.39 B(-7.5%) | $90.39 B(-9.9%) |
| Sept 2020 | - | $100.28 B(+0.1%) |
| June 2020 | - | $100.20 B(-0.8%) |
| Mar 2020 | - | $101.00 B(+3.4%) |
| Dec 2019 | $97.67 B(+9.1%) | $97.67 B(-2.4%) |
| Sept 2019 | - | $100.11 B(+6.0%) |
| June 2019 | - | $94.44 B(+1.1%) |
| Mar 2019 | - | $93.39 B(+4.3%) |
| Dec 2018 | $89.55 B(+5.0%) | $89.55 B(-2.7%) |
| Sept 2018 | - | $92.00 B(+2.4%) |
| June 2018 | - | $89.86 B(-0.1%) |
| Mar 2018 | - | $89.96 B(+5.5%) |
| Dec 2017 | $85.29 B(+18.8%) | $85.29 B(+13.7%) |
| Sept 2017 | - | $75.04 B(+1.3%) |
| June 2017 | - | $74.11 B(-1.0%) |
| Mar 2017 | - | $74.85 B(+4.3%) |
| Dec 2016 | $71.77 B(-0.3%) | $71.77 B(-1.5%) |
| Sept 2016 | - | $72.85 B(-0.7%) |
| June 2016 | - | $73.35 B(-2.2%) |
| Mar 2016 | - | $74.97 B(+4.1%) |
| Dec 2015 | $71.99 B(-0.3%) | $71.99 B(-2.7%) |
| Sept 2015 | - | $74.02 B(+0.5%) |
| June 2015 | - | $73.62 B(-1.1%) |
| Mar 2015 | - | $74.47 B(+3.2%) |
| Dec 2014 | $72.18 B(+3.5%) | $72.18 B(-2.8%) |
| Sept 2014 | - | $74.29 B(+3.7%) |
| June 2014 | - | $71.63 B(-0.6%) |
| Mar 2014 | - | $72.03 B(+3.3%) |
| Dec 2013 | $69.73 B(+28.6%) | $69.73 B(-0.9%) |
| Sept 2013 | - | $70.38 B(+4.1%) |
| June 2013 | - | $67.63 B(+18.7%) |
| Mar 2013 | - | $56.97 B(+5.0%) |
| Dec 2012 | $54.24 B(+17.4%) | $54.24 B(+5.8%) |
| Sept 2012 | - | $51.26 B(+7.0%) |
| June 2012 | - | $47.90 B(-0.5%) |
| Mar 2012 | - | $48.12 B(+4.1%) |
| Dec 2011 | $46.21 B(+8.2%) | $46.21 B(-4.0%) |
| Sept 2011 | - | $48.12 B(+8.6%) |
| June 2011 | - | $44.32 B(-1.3%) |
| Mar 2011 | - | $44.93 B(+5.2%) |
| Dec 2010 | $42.72 B(+5.7%) | $42.72 B(-0.4%) |
| Sept 2010 | - | $42.87 B(+2.1%) |
| June 2010 | - | $42.01 B(-1.0%) |
| Mar 2010 | - | $42.43 B(+5.0%) |
| Dec 2009 | $40.43 B(-17.7%) | $40.43 B(-26.3%) |
| Sept 2009 | - | $54.84 B(+5.5%) |
| June 2009 | - | $51.97 B(+0.2%) |
| Mar 2009 | - | $51.86 B(+5.5%) |
| Dec 2008 | $49.14 B(-1.0%) | $49.14 B(-7.6%) |
| Sept 2008 | - | $53.17 B(+4.4%) |
| June 2008 | - | $50.91 B(-2.9%) |
| Mar 2008 | - | $52.44 B(+5.6%) |
| Dec 2007 | $49.66 B(-0.0%) | $49.66 B(-2.7%) |
| Sept 2007 | - | $51.06 B(+1.5%) |
| June 2007 | - | $50.30 B(-5.2%) |
| Mar 2007 | - | $53.06 B(+6.8%) |
| Dec 2006 | $49.67 B | $49.67 B(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $43.99 B(+8.3%) |
| June 2006 | - | $40.63 B(-2.6%) |
| Mar 2006 | - | $41.72 B(+10.9%) |
| Dec 2005 | $37.61 B(+6.0%) | $37.61 B(-1.1%) |
| Sept 2005 | - | $38.03 B(+4.4%) |
| June 2005 | - | $36.45 B(+1.8%) |
| Mar 2005 | - | $35.78 B(+0.8%) |
| Dec 2004 | $35.49 B(+20.8%) | $35.49 B(+0.4%) |
| Sept 2004 | - | $35.35 B(+10.4%) |
| June 2004 | - | $32.00 B(+0.9%) |
| Mar 2004 | - | $31.71 B(+7.9%) |
| Dec 2003 | $29.38 B(-2.8%) | $29.38 B(-5.8%) |
| Sept 2003 | - | $31.19 B(+7.8%) |
| June 2003 | - | $28.92 B(-17.1%) |
| Mar 2003 | - | $34.91 B(+15.4%) |
| Dec 2002 | $30.24 B(+23.8%) | $30.24 B(+3.9%) |
| Sept 2002 | - | $29.10 B(+8.8%) |
| June 2002 | - | $26.74 B(-0.2%) |
| Mar 2002 | - | $26.79 B(+9.7%) |
| Dec 2001 | $24.43 B(+24.6%) | $24.43 B(+1.9%) |
| Sept 2001 | - | $23.97 B(+9.4%) |
| June 2001 | - | $21.90 B(+2.1%) |
| Mar 2001 | - | $21.44 B(+9.4%) |
| Dec 2000 | $19.60 B(+6.2%) | $19.60 B(+0.8%) |
| Sept 2000 | - | $19.45 B(+7.6%) |
| June 2000 | - | $18.09 B(+24.1%) |
| Mar 2000 | - | $14.58 B(-21.0%) |
| Dec 1999 | $18.46 B(+61.4%) | $18.46 B(+41.1%) |
| Sept 1999 | - | $13.09 B(+5.8%) |
| June 1999 | - | $12.37 B(+0.9%) |
| Mar 1999 | - | $12.25 B(+7.1%) |
| Dec 1998 | $11.44 B(+22.4%) | $11.44 B(+910.1%) |
| Sept 1998 | - | $1.13 B(-88.6%) |
| June 1998 | - | $9.93 B(+1.3%) |
| Mar 1998 | - | $9.80 B(+4.8%) |
| Dec 1997 | $9.35 B(+16.6%) | $9.35 B(-572.9%) |
| Sept 1997 | - | -$1.98 B(-123.5%) |
| June 1997 | - | $8.41 B(+0.2%) |
| Mar 1997 | - | $8.40 B(+4.8%) |
| Dec 1996 | $8.02 B(+16.9%) | $8.02 B(+4.0%) |
| Sept 1996 | - | $7.71 B(+7.1%) |
| June 1996 | - | $7.19 B(+0.1%) |
| Mar 1996 | - | $7.18 B(+4.7%) |
| Dec 1995 | $6.86 B(+15.4%) | $6.86 B(+3.7%) |
| Sept 1995 | - | $6.61 B(+6.9%) |
| June 1995 | - | $6.19 B(-0.2%) |
| Mar 1995 | - | $6.20 B(+4.3%) |
| Dec 1994 | $5.94 B(+13.4%) | $5.94 B(+3.2%) |
| Sept 1994 | - | $5.76 B(+6.2%) |
| June 1994 | - | $5.42 B(-0.7%) |
| Mar 1994 | - | $5.46 B(+4.2%) |
| Dec 1993 | $5.24 B(+2.4%) | $5.24 B(+3.0%) |
| Sept 1993 | - | $5.09 B(-4.0%) |
| June 1993 | - | $5.30 B(-0.3%) |
| Mar 1993 | - | $5.31 B(+3.8%) |
| Dec 1992 | $5.12 B(+6.8%) | $5.12 B(-2.0%) |
| Sept 1992 | - | $5.23 B(+6.0%) |
| June 1992 | - | $4.93 B(-0.8%) |
| Mar 1992 | - | $4.97 B(+3.6%) |
| Dec 1991 | $4.79 B(+6.3%) | $4.79 B(-2.2%) |
| Sept 1991 | - | $4.90 B(+5.9%) |
| June 1991 | - | $4.63 B(-0.9%) |
| Mar 1991 | - | $4.67 B(+3.5%) |
| Dec 1990 | $4.51 B(+9.9%) | $4.51 B(+11.3%) |
| Sept 1990 | - | $4.05 B(-3.8%) |
| June 1990 | - | $4.21 B(-1.1%) |
| Mar 1990 | - | $4.26 B(+3.7%) |
| Dec 1989 | $4.11 B(+11.0%) | $4.11 B(+11.0%) |
| Dec 1988 | $3.70 B(+11.1%) | $3.70 B(+11.1%) |
| Dec 1987 | $3.33 B(+13.4%) | $3.33 B(+13.4%) |
| Dec 1986 | $2.93 B(+15.3%) | $2.93 B(+15.3%) |
| Dec 1985 | $2.54 B(+15.8%) | $2.54 B(+15.8%) |
| Dec 1984 | $2.20 B | $2.20 B |
FAQ
- What is Pfizer annual retained earnings?
- What is the all time high annual retained earnings for Pfizer?
- What is Pfizer annual retained earnings year-on-year change?
- What is Pfizer quarterly retained earnings?
- What is the all time high quarterly retained earnings for Pfizer?
- What is Pfizer quarterly retained earnings year-on-year change?
What is Pfizer annual retained earnings?
The current annual retained earnings of PFE is $118.35 B
What is the all time high annual retained earnings for Pfizer?
Pfizer all-time high annual retained earnings is $125.66 B
What is Pfizer annual retained earnings year-on-year change?
Over the past year, PFE annual retained earnings has changed by -$7.30 B (-5.81%)
What is Pfizer quarterly retained earnings?
The current quarterly retained earnings of PFE is $121.06 B
What is the all time high quarterly retained earnings for Pfizer?
Pfizer all-time high quarterly retained earnings is $131.10 B
What is Pfizer quarterly retained earnings year-on-year change?
Over the past year, PFE quarterly retained earnings has changed by -$5.35 B (-4.23%)